Literature DB >> 18060882

Regulation of CD20 expression by radiation-induced changes in intracellular redox status.

Damodar Gupta1, Meredith E Crosby, Alexandru Almasan, Roger M Macklis.   

Abstract

Increasing the levels of CD20 expression in cells that harbor low CD20 levels may enhance their responsiveness to CD20-specific antibody therapies. Here, we examined the regulation of CD20 expression after treatment with 0.5-2.0 Gy X-irradiation and hydrogen peroxide (H(2)O(2)), in the presence or absence of known antioxidants, in the Burkitt lymphoma cell lines Daudi and Raji. Irradiation of cells enhanced cell-surface CD20 expression; the kinetics and extent of this change were cell-type specific and time-dependent. The kinetics of reactive oxygen species generation and changes in mitochondrial membrane potential after irradiation were also correlated with changes in CD20 expression. Raji and Daudi cells treated with H(2)O(2) showed a 2-to 2.5-fold increase in CD20 expression at 12 and 20 h, respectively. Buthionine sulfoximine, which depletes glutathione, also increased surface CD20, whereas antioxidants, such as PEG-catalase, PEG-SOD, vitamin C, and amifostine, decreased CD20 expression induced by radiation or H(2)O(2). The antioxidant-mediated decrease in CD20 expression induced by radiation or H(2)O(2) suggests a mechanism involving redox regulation. These results demonstrate the critical role of radiation-induced oxidative stress in CD20 expression and may have implications for defining and improving the efficacy of CD20-targeted antibody therapy and radioimmunotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060882      PMCID: PMC2917596          DOI: 10.1016/j.freeradbiomed.2007.10.048

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  38 in total

1.  CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.

Authors:  J Golay; M Lazzari; V Facchinetti; S Bernasconi; G Borleri; T Barbui; A Rambaldi; M Introna
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

2.  Ionizing radiation induces CD20 surface expression on human B cells.

Authors:  S Kunala; R M Macklis
Journal:  Int J Cancer       Date:  2001-06-20       Impact factor: 7.396

Review 3.  Radioprotectants: current status and new directions.

Authors:  David J Grdina; Jeffrey S Murley; Yasushi Kataoka
Journal:  Oncology       Date:  2002       Impact factor: 2.935

4.  E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.

Authors:  M E Crosby; J Jacobberger; D Gupta; R M Macklis; A Almasan
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

5.  Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1)-transfected human embryonic kidney cells: a method to resolve ionic dependence of VR1-mediated cell death.

Authors:  Elfrida R Grant; Adrienne E Dubin; Sui-Po Zhang; Robert A Zivin; Zhong Zhong
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

6.  Rapid oxidation of dichlorodihydrofluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species.

Authors:  Tomoko Ohashi; Atsushi Mizutani; Akira Murakami; Shosuke Kojo; Tetsuro Ishii; Shigeru Taketani
Journal:  FEBS Lett       Date:  2002-01-30       Impact factor: 4.124

7.  The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction.

Authors:  Q Chen; Y-C Chai; S Mazumder; C Jiang; R M Macklis; G M Chisolm; A Almasan
Journal:  Cell Death Differ       Date:  2003-03       Impact factor: 15.828

8.  CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.

Authors:  Steven P Treon; Linda M Pilarski; Andrew R Belch; Abigail Kelliher; Frederic I Preffer; Yoshihito Shima; Constantine S Mitsiades; Nicholas S Mitsiades; Agnieszka J Szczepek; Leonard Ellman; David Harmon; Michael L Grossbard; Kenneth C Anderson
Journal:  J Immunother       Date:  2002 Jan-Feb       Impact factor: 4.456

Review 9.  Reactive oxygen species and regulation of gene expression.

Authors:  K T Turpaev
Journal:  Biochemistry (Mosc)       Date:  2002-03       Impact factor: 2.487

10.  Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.

Authors:  Taghi Manshouri; Kim-anh Do; Xuemei Wang; Francis J Giles; Susan M O'Brien; Helen Saffer; Deborah Thomas; Iman Jilani; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Journal:  Blood       Date:  2002-11-21       Impact factor: 22.113

View more
  15 in total

1.  DNA damage response and apoptosis.

Authors:  Dragos Plesca; Suparna Mazumder; Alexandru Almasan
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

2.  Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.

Authors:  Arishya Sharma; Allison J Janocha; Brian T Hill; Mitchell R Smith; Serpil C Erzurum; Alexandru Almasan
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

3.  Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma.

Authors:  Yazan Abuodeh; Kamran Ahmed; Michelle Echevarria; Arash Naghavi; G Daniel Grass; Timothy J Robinson; Michael Tomblyn; Bijal Shah; Julio Chavez; Celeste Bello; Ghassan El-Haddad; Louis Harrison; Sungjune Kim
Journal:  Ther Adv Hematol       Date:  2017-02-01

4.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

5.  Rituximab sensitizes a Burkitt lymphoma cell line to cell killing by X-irradiation.

Authors:  Min Fengling; Liu Fenju; Wen Wanxin; Zhai Lijia; Tong Jiandong; Wang Zu; Yuan Xin; Gao Qingxiang
Journal:  Radiat Environ Biophys       Date:  2009-08-04       Impact factor: 1.925

6.  Anticancer Action of Psilostachyin-A in 5-Fluorouracil-Resistant Human Liver Carcinoma are Mediated Through Autophagy Induction, G2/M Phase Cell Cycle Arrest and Inhibiting Extracellular-Signal-Regulated Kinase/Mitogen Activated Protein Kinase (ERK/MAPK) Signaling Pathway.

Authors:  Jun Liu; Yan Liu; Yan Liu; Lei Huang; Guoliang Wang; Jun Wang; Xiangang Xu; Chengxian Shi; Jianzhao Huang
Journal:  Med Sci Monit       Date:  2019-09-07

7.  Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Andrew M Evens; Laurie H Sehn; Pedro Farinha; Beverly P Nelson; Adekunle Raji; Yi Lu; Adam Brakman; Vamsi Parimi; Jane N Winter; Paul T Schumacker; Randy D Gascoyne; Leo I Gordon
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

8.  Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.

Authors:  Jie Jin; Lihong Cao; Lijun Wang; Zhaoming Wang; Wei Ding; Liping Mao; Shanshan Suo; Zhengping Zhuang; Hongyan Tong
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

9.  Defective chromatin recruitment and retention of NHEJ core components in human tumor cells expressing a Cyclin E fragment.

Authors:  Payel Chatterjee; Dragos Plesca; Suparna Mazumder; Jean Boutros; Steven M Yannone; Alexandru Almasan
Journal:  Nucleic Acids Res       Date:  2013-09-09       Impact factor: 16.971

10.  Surface levels of CD20 determine anti-CD20 antibodies mediated cell death in vitro.

Authors:  Vijay Singh; Damodar Gupta; Rajesh Arora; Rajendra Prashad Tripathi; Alexandru Almasan; Roger M Macklis
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.